Sign In
Buy VTRS
$16.31
-0.0800 (-0.488%)
At Close: Jul 14, 2026
NEW YORK CITY, NY / ACCESS Newswire / May 9, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Viatris
NEW YORK , May 9, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) of a class action securities lawsuit. CLASS DEFINITION: The
Levi & Korsinsky Reminds Viatris Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 3, 2025 - VTRS
10:15pm, Thursday, 08'th May 2025
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / May 8, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors tha
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Viatris Lawsuit - VTRS
04:15pm, Thursday, 08'th May 2025
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
03:45pm, Thursday, 08'th May 2025
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
Viatris Discloses Positive Data From 2 Drugs In Earnings Report, Stock Soars
02:55pm, Thursday, 08'th May 2025
Viatris Inc. VTRS on Thursday, released data from Phase 3 study evaluating the contraceptive efficacy and safety of XULANE LO low dose weekly dermal patch of 150 mcg norelgestromin and 17.5 mcg ethin
Contact Levi & Korsinsky by June 3, 2025 Deadline to Join Class Action Against Viatris Inc.(VTRS)
01:53pm, Thursday, 08'th May 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) of a class action securities lawsuit.
Viatris Q1 Earnings and Revenues Beat Estimates, Stock Gains
01:40pm, Thursday, 08'th May 2025
VTRS Q1 earnings and sales beat estimates. Brands business continues to perform well backed by expansion of portfolio.
Viatris Q1 Earnings Review: Shares Are Up, Time To Sell (Rating Downgrade)
12:41pm, Thursday, 08'th May 2025
Viatris Inc.'s Q1 2025 earnings show declining revenues and profits, yet the stock rose nearly 10% due to stable full-year guidance and positive pipeline updates. The company's significant debt reduct
Shareholders of Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS
12:15pm, Thursday, 08'th May 2025
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW ORLEANS, May 08, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until June 3, 2025 to file lead plaintiff applications in a securiti
Viatris (VTRS) Reports Q1 Earnings: What Key Metrics Have to Say
10:36am, Thursday, 08'th May 2025
While the top- and bottom-line numbers for Viatris (VTRS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare t
Viatris Inc. (VTRS) Q1 2025 Earnings Call Transcript
10:35am, Thursday, 08'th May 2025
Viatris Inc. (NASDAQ:VTRS ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Bill Szablewski - Head of Capital Markets Scott Smith - CEO Philippe Martin - Chief R&D Officer
Viatris (VTRS) Beats Q1 Earnings and Revenue Estimates
09:20am, Thursday, 08'th May 2025
Viatris (VTRS) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.67 per share a year ago.
